How should folliculitis be documented in the medical record?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Documentation of Folliculitis in the Medical Record

Document folliculitis by clearly specifying the anatomical location, clinical presentation (papules, pustules, or both), distribution pattern, and whether the condition is superficial or extends deeper into the dermis, as this distinction is critical for treatment decisions and differs from related conditions like furuncles or carbuncles. 1

Essential Clinical Documentation Elements

Anatomical Classification and Location

  • Record the specific anatomical compartment involved: folliculitis affects the superficial aspect of the hair follicle (infundibulum or isthmus), whereas furuncles extend through the dermis into subcutaneous tissue 2, 1
  • Document the precise body location: scalp, face, trunk, extremities, or groin, as location influences differential diagnosis 3, 4
  • Note distribution pattern: isolated, clustered, or diffuse involvement 5

Clinical Morphology

  • Describe primary lesions: 1mm-wide vesicles, pustules, papulopustules (acute), or hyperkeratotic plugs (chronic) 5
  • Document associated features: erythema, tenderness, pruritus, pain, or surrounding inflammation 2, 1
  • Record presence of hair tufting or follicular plugging if observed on examination 6

Critical Diagnostic Distinctions

Chart what folliculitis is NOT to avoid misclassification: 1

  • Exclude purulent collections: Do not label abscesses, carbuncles, or septic bursitis as "cellulitis with folliculitis"—the primary treatment differs fundamentally (drainage vs. antibiotics) 1
  • Differentiate from furuncles: Furuncles have deeper suppuration with inflammatory nodules and overlying pustules through which hair emerges 2, 1
  • Distinguish from carbuncles: Coalescent inflammatory masses with pus draining from multiple follicular orifices, typically on the posterior neck 2, 1

Diagnostic Workup Documentation

When to Obtain Cultures

  • Document Gram stain and culture results for carbuncles and abscesses, though treatment without these studies is reasonable in typical cases 1
  • Consider cytology as first-line diagnostic tool: This simple, rapid, inexpensive method can reveal bacterial, fungal, viral, or parasitic pathogens and prevent months of inappropriate antibacterial therapy 7
  • Obtain cultures for recurrent cases: Document early drainage and culture results to guide targeted antibiotic therapy 1

Specific Diagnostic Considerations

  • For uniform pustules in periorificial areas with prolonged symptoms: Document lesion culture to diagnose Gram-negative folliculitis 8
  • For monomorphic truncal papules/pustules: Consider and document testing for Pityrosporum (Malassezia) folliculitis 8, 9, 10
  • For facial diffuse folliculitis resistant to antibacterial/antifungal therapy: Document consideration of herpetic folliculitis, especially if lesions developed acutely 11
  • For scalp involvement: Document histologic confirmation when diagnosis is uncertain, as clinical appearance alone is insufficient 4

Treatment Documentation

Antibiotic Use Criteria

Document the specific indication for systemic antibiotics, which are usually unnecessary unless: 2, 1

  • Extensive surrounding cellulitis is present
  • Fever or systemic inflammatory response syndrome (SIRS) criteria are met (temperature >38°C or <36°C, tachycardia >90 bpm, tachypnea >24 breaths/min, WBC >12,000 or <4,000 cells/µL)
  • Multiple lesions with cutaneous gangrene
  • Severely impaired host defenses

MRSA Considerations

  • Document rationale if MRSA coverage is initiated: MRSA is an unusual cause of typical folliculitis; coverage is indicated primarily for carbuncles/abscesses with SIRS or severe immunocompromise 1
  • For recurrent S. aureus infections: Document decolonization measures including intranasal mupirocin, chlorhexidine washes, and decontamination of personal items 1

Common Pitfalls to Document and Avoid

Misdiagnosis Prevention

  • Do not assume bacterial etiology: Superficial pustules do not always indicate infection—many noninfectious types exist 5
  • Document failed antibiotic trials: This suggests alternative etiologies (fungal, viral, or noninfectious) requiring different diagnostic approaches 11, 7
  • Avoid labeling inflamed epidermoid cysts as infectious: Inflammation typically results from cyst wall rupture, not infection; Gram stain and culture are not recommended 1

Special Populations

  • For athletes/sports participants: Document exposure history, contact with infected individuals, and shared equipment use 12
  • For immunocompromised patients: Document broader differential including atypical presentations and need for more aggressive diagnostic workup 3

Outcome and Follow-up Documentation

  • Record treatment response: Duration to improvement, complete resolution, or treatment failure 13
  • Document recurrence patterns: Time to relapse (typically 12-23 months for some variants) and triggers 6
  • Note quality of life impact: Particularly for chronic or scarring variants like folliculitis decalvans 13, 6

References

Research

Folliculitis: recognition and management.

American journal of clinical dermatology, 2004

Research

First step in the differential diagnosis of folliculitis: cytology.

Critical reviews in microbiology, 2013

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2024

Research

Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2023

Research

Facial Herpetic Folliculitis Should Be Concerned in the Clinic: A Retrospective Case Series.

Clinical, cosmetic and investigational dermatology, 2022

Research

Management of Folliculitis Decalvans: A Systematic Review.

The Australasian journal of dermatology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.